Bold Capital Partners
Bold Capital Partners is a privately held, early-stage venture capital firm investing in transformative companies across health and life sciences and deep tech, with a portfolio spanning AI, biotech, aerospace, and synthetic biology. Founded in 2015 and headquartered in Santa Monica, it serves bold founders building convergence technologies.
- Company typePrivate
- Founded2015
- HeadquartersSanta Monica, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Bold Capital Partners does
Bold Capital Partners is a privately held, early-stage venture capital firm founded in 2015 and headquartered in Santa Monica, California, with a second office in Boston. The firm invests across two thematic pillars — Health & Life Sciences (longevity, patient-enabled health management, synthetic biology) and Deep Tech & Productivity (AI, blockchain, sensors, VR, 3D printing, robotics) — anchored by a "convergence" thesis targeting the intersection of physical, digital, virtual, and biological technologies. The portfolio spans more than 50 companies, including current holdings such as Colossal Biosciences, Centivax, Near Space Labs, ProRata.ai, Hosta AI, and Gallant Pet, alongside realized exits including Insilico Medicine (SEHK IPO), Deep Longevity (SEHK IPO), CareSignal, Mighty Buildings, IVIVA Medical, and Docbot.
The firm monetizes through the standard VC model of management fees on assets under management and carried interest on realized portfolio exits. It sources and originates deals through direct founder outreach, partner networks, and industry conference participation, and distributes capital via direct equity investments, often participating in syndicates and occasionally leading rounds (e.g., the $25 million seed for The Biological Computing Company in 2026). Marketing and deal-flow generation is supported by an active LinkedIn and Twitter presence, a published News & Ideas content hub, and the affiliated BOLD Longevity Growth (BLG.VC) sub-brand, which extends the platform into dedicated longevity investing.
The team is led by co-founder Peter Diamandis alongside managing partner Teymour Boutros-Ghali, CFO William Meeker, and principal Will Borthwick. The firm is founder/partner-led with no disclosed parent or institutional LP backing in the input data, and there is no public listing or ticker. No information on AUM, fee structure, or fund size is publicly disclosed, which limits visibility into revenue mechanics despite an evident high deal cadence across 2025-2026.
Bold Capital Partners firmographics
Firmographics- Name
- Bold Capital Partners
- Legal name
- BOLD Capital Partners
- Website
- https://boldcapitalpartners.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bold Capital Partners is a privately held, early-stage venture capital firm investing in transformative companies across health and life sciences and deep tech, with a portfolio spanning AI, biotech, aerospace, and synthetic biology. Founded in 2015 and headquartered in Santa Monica, it serves bold founders building convergence technologies.
- Ownership category
- akta.pro rank
Bold Capital Partners industry classification
Industry- Product category
- Venture Capital
- NAICS
- Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282), Investors, Nec (6799)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
- akta.pro secondary industries
- SDG / Thematic Sustainable Investment Funds (FSANAJAN), Impact Investment & Development Investment Funds (BPADACAO)
Keywords
Where Bold Capital Partners is headquartered
LocationHeadquarters
- HQ city
- Santa Monica
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Bold Capital Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Management Fees: Standard VC management fees typically charged as a percentage of assets under management
- Carried Interest: Performance-based carried interest from successful portfolio company exits and realizations
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Bold Capital Partners product offering
Product offeringCore offering
Bold Capital Partners is an early-stage venture capital firm that invests capital into founders and companies developing transformative technologies. The firm deploys funds across two main verticals: Health & Life Sciences (longevity, synthetic biology, patient-enabled health) and Deep Tech & Productivity (AI, blockchain, sensors, VR, 3D printing, robotics). Bold Capital also operates BOLD Longevity Growth (BLG.VC) as an affiliated fund vehicle focused on longevity investing.
Product overview
Bold Capital Partners is a venture capital firm that invests in people and technologies transforming the world. The firm focuses on two primary areas: Health & Life Sciences (including longevity, patient-enabled health management, synthetic biology) and Deep Tech & Productivity (including AI, blockchain, sensors, VR, 3D printing, robotics). The firm deploys capital into early-stage companies and manages investment portfolios across these transformative technology sectors.
Differentiator
Problem solved
Functional benefit
Brands
- BOLD Longevity Growth: A longevity-focused investment initiative within BOLD Capital Partners
Products and services
- Venture Capital Investment Management Early-stage venture capital investment services providing capital, strategic guidance, and network access to founders and companies developing transformative technologies. Focuses on Health & Life Sciences (longevity, synthetic biology, patient-enabled health) and Deep Tech & Productivity (AI, blockchain, sensors, VR, 3D printing, robotics).
- BOLD Longevity Growth (BLG.VC) Affiliated longevity-focused investment fund vehicle operating under the Bold Capital Partners umbrella, extending the firm's investment reach into longevity and aging-related technologies. Located at the same Santa Monica address.
Companies that use Bold Capital Partners
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Bold Capital Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Bold Capital Partners partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights5 records
Bold Capital Partners competitors and assessment
Company assessmentDirect peers
- Lux Capital: Early-stage VC investing in frontier science and technology, including deep tech, biotech, AI, and aerospace. Strong overlap with Bold's convergence-of-exponential-tech thesis and target founder profile.
- First Round Capital: Early-stage venture firm that seeds founders building category-defining companies. Comparable to Bold in stage focus (seed/Series A) and commitment to transformational technology founders.
- Founders Fund: Early-to-growth stage venture firm backing transformative technologies in biotech, aerospace, AI, and frontier tech. Comparable to Bold in willingness to invest in contrarian, science-heavy categories.
- DCVC (Data Collective): Deep-tech venture firm backing founders applying frontier science — including AI, biology, materials, and aerospace — to transform large industries. Directly comparable to Bold's deep-tech mandate.
- ARCH Venture Partners: Specialist early-stage investor in life sciences, biotech, and physical sciences. Highly comparable to Bold's health and life sciences vertical and willingness to lead deep-science rounds.
- Innovation Endeavors: Early-stage VC investing at the intersection of technology, science, and global impact. Comparable to Bold in horizontal, frontier-tech orientation and willingness to back deep-tech and biotech founders.
- Khosla Ventures: Early-stage venture firm investing across frontier technology, healthcare, and biotech with a willingness to back bold, science-driven bets. Closely comparable to Bold Capital in thesis (transformative tech, life sciences) and stage (seed to growth).
- Obvious Ventures: Venture firm investing in transformative companies across health, energy, and frontier tech with a thematic 'world positive' lens. Comparable to Bold's mission-driven framing of transformative technology.
Others
- Allen & Company: Private investment bank and investor with selective venture exposure across transformative technology. Adjacent to Bold as a fellow independent, founder-led investor with selective frontier exposure.
Broad incumbents
- Andreessen Horowitz (a16z): Large multi-stage venture firm with dedicated bio/health and frontier-tech franchises. Comparable to Bold in scope (AI, biotech, deep tech) but operates at significantly larger fund scale and brand recognition.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Bold Capital Partners social profiles
Digital presenceBold Capital Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bold Capital Partners leadership team
Management profileNumber of profiles
Profiles4 records
Bold Capital Partners funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bold Capital Partners M&A and investment
M&A and investmentM&A
Investments135 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bold Capital Partners
What does Bold Capital Partners do?
Bold Capital Partners is an early-stage venture capital firm that invests capital into founders and companies developing transformative technologies. The firm deploys funds across two main verticals: Health & Life Sciences (longevity, synthetic biology, patient-enabled health) and Deep Tech & Productivity (AI, blockchain, sensors, VR, 3D printing, robotics). Bold Capital also operates BOLD Longevity Growth (BLG.VC) as an affiliated fund vehicle focused on longevity investing.
Is Bold Capital Partners a public or private company?
Bold Capital Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bold Capital Partners founded?
Bold Capital Partners was founded in 2015. It employs 11 to 50 people.
Where is Bold Capital Partners based?
Bold Capital Partners is headquartered in Santa Monica, United States, in the North America region.
How does Bold Capital Partners make money?
Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.
Who are Bold Capital Partners's main competitors?
Direct peers on record are Lux Capital, First Round Capital, Founders Fund, DCVC (Data Collective), ARCH Venture Partners, Innovation Endeavors, Khosla Ventures and Obvious Ventures. Allen & Company is listed as an others. Andreessen Horowitz (a16z) is listed as a broad incumbent.
Does Bold Capital Partners have an API?
No public API is recorded for Bold Capital Partners.
What industry is Bold Capital Partners in?
Bold Capital Partners's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAJAN, SDG / Thematic Sustainable Investment Funds. Its NAICS code is 523 and its SIC code is 6282.